High Tower Advisors, LLC Baxter International Inc Transaction History

High Tower Advisors, LLC

  • $68.3 Billion
  • Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Baxter International Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 64,804 shares of BAX stock, worth $2.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,804
Previous 56,527 14.64%
Holding current value
$2.15 Million
Previous $1.89 Million 30.16%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$32.85 - $40.26 $271,899 - $333,232
8,277 Added 14.64%
64,804 $2.46 Million
Q2 2024

Aug 13, 2024
BUY
$32.87 - $43.55 $43,980 - $58,269
1,338 Added 2.42%
56,527 $1.89 Million
Q1 2024

May 06, 2024
BUY
$37.88 - $43.77 $128,602 - $148,599
3,395 Added 6.55%
55,189 $2.36 Million
Q4 2023

Feb 12, 2024
SELL
$31.71 - $38.95 $351,759 - $432,072
-11,093 Reduced 17.64%
51,794 $2 Million
Q3 2023

Nov 08, 2023
SELL
$37.32 - $49.29 $195,220 - $257,835
-5,231 Reduced 7.68%
62,887 $2.37 Million
Q2 2023

Aug 14, 2023
BUY
$39.98 - $47.68 $25,587 - $30,515
640 Added 0.95%
68,118 $3.1 Million
Q1 2023

May 11, 2023
SELL
$37.58 - $52.57 $2.42 Million - $3.38 Million
-64,372 Reduced 48.82%
67,478 $2.74 Million
Q4 2022

Feb 08, 2023
BUY
$49.7 - $57.71 $101,885 - $118,305
2,050 Added 1.58%
131,850 $6.72 Million
Q3 2022

Nov 09, 2022
SELL
$53.86 - $66.8 $127,863 - $158,583
-2,374 Reduced 1.8%
129,800 $7 Million
Q2 2022

Aug 10, 2022
SELL
$63.83 - $80.0 $95,872 - $120,160
-1,502 Reduced 1.12%
132,174 $8.48 Million
Q1 2022

May 12, 2022
BUY
$76.85 - $89.45 $234,469 - $272,911
3,051 Added 2.34%
133,676 $10.4 Million
Q4 2021

Feb 10, 2022
BUY
$74.57 - $87.19 $298 - $348
4 Added 0.0%
130,625 $11.2 Million
Q3 2021

Nov 12, 2021
SELL
$73.77 - $83.61 $45,811 - $51,921
-621 Reduced 0.47%
130,621 $10.5 Million
Q2 2021

Aug 06, 2021
BUY
$80.5 - $88.01 $641,182 - $700,999
7,965 Added 6.46%
131,242 $10.6 Million
Q1 2021

May 10, 2021
BUY
$76.38 - $86.03 $350,431 - $394,705
4,588 Added 3.87%
123,277 $10.4 Million
Q4 2020

Feb 10, 2021
SELL
$75.39 - $82.36 $4.75 Million - $5.19 Million
-63,068 Reduced 34.7%
118,689 $9.52 Million
Q3 2020

Nov 13, 2020
BUY
$78.33 - $90.73 $487,369 - $564,522
6,222 Added 3.54%
181,757 $14.6 Million
Q2 2020

Aug 10, 2020
BUY
$78.66 - $94.14 $3.32 Million - $3.98 Million
42,260 Added 31.71%
175,535 $15.1 Million
Q1 2020

May 21, 2020
BUY
$71.57 - $93.3 $9.54 Million - $12.4 Million
133,275 New
133,275 $10.8 Million
Q4 2019

Feb 14, 2020
SELL
$76.7 - $88.45 $9.78 Million - $11.3 Million
-127,457 Closed
0 $0
Q3 2019

Nov 12, 2019
BUY
$81.4 - $89.78 $54,049 - $59,613
664 Added 0.52%
127,457 $11.1 Million
Q2 2019

Aug 13, 2019
BUY
$73.44 - $82.41 $1.05 Million - $1.18 Million
14,302 Added 12.71%
126,793 $10.4 Million
Q1 2019

May 15, 2019
BUY
$64.48 - $81.31 $257,210 - $324,345
3,989 Added 3.68%
112,491 $9.14 Million
Q4 2018

Feb 14, 2019
SELL
$61.45 - $77.8 $584,205 - $739,644
-9,507 Reduced 8.06%
108,502 $7.15 Million
Q3 2018

Nov 09, 2018
SELL
$70.71 - $77.75 $299,668 - $329,504
-4,238 Reduced 3.47%
118,009 $9.09 Million
Q2 2018

Aug 14, 2018
SELL
$63.43 - $75.41 $129,777 - $154,288
-2,046 Reduced 1.65%
122,247 $9.01 Million
Q1 2018

May 15, 2018
SELL
$62.56 - $72.26 $12,824 - $14,813
-205 Reduced 0.16%
124,293 $8.1 Million
Q4 2017

Feb 14, 2018
SELL
$61.45 - $66.05 $863,495 - $928,134
-14,052 Reduced 10.14%
124,498 $8.03 Million
Q3 2017

Nov 14, 2017
BUY
$59.5 - $64.61 $83,419 - $90,583
1,402 Added 1.02%
138,550 $8.7 Million
Q2 2017

Aug 14, 2017
BUY
N/A
137,148
137,148 $8.29 Million

Others Institutions Holding BAX

# of Institutions
1,006
Shares Held
451M
Call Options Held
2.79M
Put Options Held
2.44M
View Full List

About BAXTER INTERNATIONAL INC

BAX Quotes by TradingView
  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email